Tumor mutational burden and immune signatures interplay in renal cell carcinoma

被引：18
作者：
Yakirevich, Evgeny
Patel, Nimesh R.
机构：
[1] Brown Univ, Rhode Isl Hosp, Dept Pathol, Providence, RI 02903 USA
[2] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2020年 / 8卷 / 06期
关键词：
CANCER; LYMPHOCYTES; NEOANTIGENS; ACTIVATION;
D O I：
10.21037/atm.2020.02.81
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
[21]   Association of tumor mutational burden with genomic alterations in Chinese urothelial carcinoma [J].
Chen, Xusheng ;
Ou, Zhenyu ;
Wang, Lei ;
Zhang, Zhenting ;
Fan, Xiaodong ;
Liu, Huanhuan ;
Wang, Wenping ;
Zhang, Yanrui ;
Zhu, Jun ;
Liang, Xiayuan ;
Lou, Feng ;
Cao, Shanbo ;
Yao, Ye ;
Wang, Huina ;
Yao, Xin .
MOLECULAR CARCINOGENESIS, 2022, 61 (03) :311-321
[22]   Mutational signatures define immune and Wnt-associated subtypes of ampullary carcinoma [J].
Zhuravleva, Ekaterina ;
Lewinska, Monika ;
O'Rourke, Colm J. ;
Pea, Antonio ;
Rashid, Asif ;
Hsing, Ann W. ;
Taranta, Andrzej ;
Chang, David ;
Gao, Yu-Tang ;
Koshiol, Jill ;
Oliveira, Rui Caetano ;
Andersen, Jesper B. .
GUT, 2025, 74 (05) :804-814
[23]   Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma [J].
Wong, Mary ;
Kim, Jong T. ;
Cox, Brian ;
Larson, Brent K. ;
Kim, Stacey ;
Waters, Kevin M. ;
Vail, Eric ;
Guindi, Maha .
HEPATIC ONCOLOGY, 2021, 8 (04)
[24]   Integrated analysis of the immunological and genetic status in and across cancer types: impact of mutational signatures beyond tumor mutational burden [J].
Budczies, Jan ;
Seidel, Anja ;
Christopoulos, Petros ;
Endris, Volker ;
Kloor, Matthias ;
Gyorffy, Balazs ;
Seliger, Barbara ;
Schirmacher, Peter ;
Stenzinger, Albrecht ;
Denkert, Carsten .
ONCOIMMUNOLOGY, 2018, 7 (12)
[25]   Tumor mutational burden presents limiting effects on predicting the efficacy of immune checkpoint inhibitors and prognostic assessment in adrenocortical carcinoma [J].
Xu, Fangshi ;
Guan, Yibing ;
Zhang, Peng ;
Xue, Li ;
Ma, Yubo ;
Gao, Mei ;
Chong, Tie ;
Ren, Bin-Cheng .
BMC ENDOCRINE DISORDERS, 2022, 22 (01)
[26]   Germline variants predictive of tumor mutational burden and immune checkpoint inhibitor efficacy [J].
Chatrath, Ajay ;
Ratan, Aakrosh ;
Dutta, Anindya .
ISCIENCE, 2021, 24 (03)
[27]   Tumor mutational burden standardization initiatives: Recommendations for consistent tumor mutational burden assessment in clinical samples to guide immunotherapy treatment decisions [J].
Stenzinger, Albrecht ;
Allen, Jeffrey D. ;
Maas, Joerg ;
Stewart, Mark D. ;
Merino, Diana M. ;
Wempe, Madison M. ;
Dietel, Manfred .
GENES CHROMOSOMES & CANCER, 2019, 58 (08) :578-588
[28]   Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis [J].
Rodrigo, Juan P. ;
Sanchez-Canteli, Mario ;
Otero-Rosales, Maria ;
Martinez-Camblor, Pablo ;
Hermida-Prado, Francisco ;
Garcia-Pedrero, Juana M. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
[29]   Assessment of hazard immune-related genes and tumor immune infiltrations in renal cell carcinoma [J].
Chen, Hongxi ;
Xie, Jinliang ;
Jin, Peng .
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (11) :7096-7113
[30]   Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery [J].
Moreira, A. ;
Poulet, A. ;
Masliah-Planchon, J. ;
Lecerf, C. ;
Vacher, S. ;
Cherif, L. Larbi ;
Dupain, C. ;
Marret, G. ;
Girard, E. ;
Syx, L. ;
Hoffmann, C. ;
Jeannot, E. ;
Klijanienko, J. ;
Guillou, I. ;
Mariani, O. ;
Dubray-Vautrin, A. ;
Badois, N. ;
Lesnik, M. ;
Choussy, O. ;
Calugaru, V. ;
Borcoman, E. ;
Baulande, S. ;
Legoix, P. ;
Albaud, B. ;
Servant, N. ;
Bieche, I. ;
Le Tourneau, C. ;
Kamal, M. .
ESMO OPEN, 2021, 6 (04)
12345